Med24
Public Health 16. 10. 2026 • 2 min read • medical-news

Hot flashes, night sweats, insomnia – OB-GYNS set new rules for menopause treatment

For the first time since 2014, the American College of Obstetricians and Gynecologists has updated its guidelines for the treatment of symptoms commonly associated with menopause.

Hot flashes, night sweats, insomnia – OB-GYNS set new rules for menopause treatment

The American College of Obstetricians and Gynecologists (ACOG) has updated its guidelines for menopause treatment, reflecting advancements in research and patient care. The updated guidance emphasizes a personalized approach to managing symptoms like hot flashes, insomnia, and mood swings. ACOG recommends HRT, particularly for newly menopausal women within 10 years of their final menstrual period or before age 60, noting its safety is now well-established. However, HRT is contraindicated in individuals with undiagnosed abnormal genital bleeding, certain gynecologic cancer histories, blood clots, stroke, heart attack, liver disease, or a suspected pregnancy. Women with a uterus require a combination of estrogen and progestogen to mitigate the risk of uterine lining growth and endometrial cancer.

For women without a uterus, estrogen alone is recommended. Alongside HRT, the guidelines highlight new nonhormonal treatments, including fezolinetant (Veozah) and elinzanetant (Lynkuet), which target the physiological mechanisms of thermoregulation and sleep cycles. Gabapentin, an anticonvulsant, is also recommended for those who cannot tolerate hormone therapies. ACOG acknowledges the effectiveness of cognitive behavioral therapy, mindfulness-based interventions, exercise, clinical hypnosis, and acupuncture, though the evidence supporting these options is considered weaker than that for HRT.

Sponsored content

Approximately 2 million women experience menopause annually, with an average age of 49.9 years. Demand for HRT is increasing, following the removal of certain warnings by the FDA. Current shortages of transdermal estrogen therapy underscore the need for a broader discussion of treatment options. ACOG stresses the importance of individualized care, encouraging patients to discuss the pros and cons of various treatments with trusted clinicians, avoiding oversimplification and misinformation. The updated guidelines prioritize a comprehensive approach, incorporating lifestyle modifications and a range of therapeutic interventions to address individual patient needs and preferences.

Original Scientific Source
medical-news
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement